Author:
Akın Yusuf,Karasu Mehdi,Deniz Abdulmelik,Mirzaoğlu Çetin,Bolayır Hasan Ata
Abstract
Abstract
İntroduction
Patients with normal coronary arteries in whom increased vasospasm cannot be detected with the stress test should be evaluated in terms of cardiac syndrome x (CSX). İnflammatory systems are effective in endothelial activation and dysfunction in CSX. The systemic immune inflammation index (SII) is thought to be an important factor in determining the course of diseases, especially in infectious diseases or other diseases, as an indicator of the inflammation process. The aim of this study is to determine the role of SII levels in the diagnosis of CSX disease.
Methods
The study group included 80 patients who applied to the cardiology department of Fırat University with typical anginal complaints between October 2021 and April 2022, and were diagnosed with ischemia after the myocardial perfusion scan, and then coronary angiography was performed and normal coronary arteries were observed.
Results
When the study and control groups were examined according to age, gender and body mass index, hypertension, smoking, diabetes mellitus, dyslipidemia and family history, no statistical significant difference was observed between the groups. It was observed that there was a significant difference between the high sensitive C- reactive protin levels of the individuals in the study and control groups (p = 0.028). SII levels measured in samples taken from patients were significantly higher than control subjects (p = 0.003). SII cutoff at admission was 582 with 82% sensitivity and 84% specificity (area under the curve 0.972; 95% CI:0.95–0.98;p < 0.001).
Conclusion
It has been demonstrated that systemic SII parameters, which can be simply calculated with the data obtained from the complete blood count and do not require additional costs, can contribute to the prediction of CSX disease.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Vermeltfoort IAC, Raijmakers PGHM, Riphagen II, et al. Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol. 2010;99(8):475–81.
2. Özer YG, Önal B, Özen D, et al. Kardiyak Sendrom X Hastalarinda İnterlökin-17 Serum Seviyesi ve Il-17 Geni-152g/A Polimorfizminin Araştirilmasi. J Acad Res Med. 2018;8(3):78–89.
3. Çetin MS, Çetin EHÖ, Canpolat U, et al. Kardiyak sendrom X’li hastalarda artmış miyokart enerji tüketimi: Çok iş çok ağrı. Turk Kardiyol Dern Ars. 2018;46(6):446–54.
4. Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Med Novel Techno Devices. 2019;4:25–65.
5. Ouellette ML, Löffler AI, Beller GA, et al. Clinical characteristics sex differences and outcomes in patients with normal or near-normal coronary arteries non-obstructive or obstructive coronary artery disease. J Am Heart Assoc. 2018;7(10):007965.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献